DE4343062C1 - Special liniment for the treatment of all types of joint inflammation, especially rheumatoid arthritis and osteoarthritis - Google Patents
Special liniment for the treatment of all types of joint inflammation, especially rheumatoid arthritis and osteoarthritisInfo
- Publication number
- DE4343062C1 DE4343062C1 DE19934343062 DE4343062A DE4343062C1 DE 4343062 C1 DE4343062 C1 DE 4343062C1 DE 19934343062 DE19934343062 DE 19934343062 DE 4343062 A DE4343062 A DE 4343062A DE 4343062 C1 DE4343062 C1 DE 4343062C1
- Authority
- DE
- Germany
- Prior art keywords
- grams
- inflammation
- special
- disease
- joints
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 206010003246 arthritis Diseases 0.000 title claims abstract description 8
- 208000018937 joint inflammation Diseases 0.000 title claims abstract description 4
- 201000008482 osteoarthritis Diseases 0.000 title description 4
- 229940040145 liniment Drugs 0.000 title 1
- 239000000865 liniment Substances 0.000 title 1
- 206010039073 rheumatoid arthritis Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 claims abstract description 4
- 230000001684 chronic effect Effects 0.000 claims abstract 2
- 239000000341 volatile oil Substances 0.000 claims abstract 2
- 239000002674 ointment Substances 0.000 claims description 8
- 201000010099 disease Diseases 0.000 claims description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 6
- 206010061218 Inflammation Diseases 0.000 claims description 5
- 230000004054 inflammatory process Effects 0.000 claims description 5
- 210000001503 joint Anatomy 0.000 claims description 5
- 206010036030 Polyarthritis Diseases 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 3
- 229910052740 iodine Inorganic materials 0.000 claims description 3
- 239000011630 iodine Substances 0.000 claims description 3
- 210000000707 wrist Anatomy 0.000 claims description 3
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 claims description 2
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 claims description 2
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 claims description 2
- 208000004575 Infectious Arthritis Diseases 0.000 claims description 2
- 230000001760 anti-analgesic effect Effects 0.000 claims description 2
- 230000000844 anti-bacterial effect Effects 0.000 claims description 2
- 230000000922 anti-bactericidal effect Effects 0.000 claims description 2
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 2
- 229960004544 cortisone Drugs 0.000 claims description 2
- 208000030428 polyarticular arthritis Diseases 0.000 claims description 2
- 230000000750 progressive effect Effects 0.000 claims description 2
- 201000001223 septic arthritis Diseases 0.000 claims description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims 4
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 claims 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims 2
- 229960004889 salicylic acid Drugs 0.000 claims 2
- 239000010642 eucalyptus oil Substances 0.000 claims 1
- 229940044949 eucalyptus oil Drugs 0.000 claims 1
- 235000011187 glycerol Nutrition 0.000 claims 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 claims 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 claims 1
- 229960001047 methyl salicylate Drugs 0.000 claims 1
- 235000019477 peppermint oil Nutrition 0.000 claims 1
- 229940051879 analgesics and antipyretics salicylic acid and derivative Drugs 0.000 abstract 1
- 229920000742 Cotton Polymers 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 1
- KUVIULQEHSCUHY-XYWKZLDCSA-N Beclometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O KUVIULQEHSCUHY-XYWKZLDCSA-N 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 206010052098 Iodine allergy Diseases 0.000 description 1
- 241000009298 Trigla lyra Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 208000026816 acute arthritis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 229940124641 pain reliever Drugs 0.000 description 1
- 101150008563 spir gene Proteins 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/18—Iodine; Compounds thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Rp./Acid. Salyc. gta 0,25
Methyl. Salyc. gta 0,40
Sol. Jodi 5% gta 0,80
Kalii Jodati gta 0,05
Olei Eucalipti gta 0,20
Olei Menthae piper. gta 0,20
Spir. dil. gta 2,50
Boli alba steril gta 0,142,00
Glycerini ad gta 300,00Rp./Acid. Salyc. gta 0.25
Methyl. Salyc. gta 0.40
Sol. Jodi 5% gta 0.80
Kalii Jodati gta 0.05
Olei Eucalipti gta 0.20
Olei Menthae piper. gta 0.20
Spir. Dil. gta 2.50
Boli alba sterile gta 0.142.00
Glycerini ad gta 300.00
M.f.ung.M.f.ung.
Zur Behandlung von akuten und chronischen Gelenkentzündungen, besonders bei "PCP". Schmerzstillendes Mittel bei Arthrosen.For the treatment of acute and chronic arthritis, especially at "PCP". Pain reliever for arthrosis.
Gegenanzeige
Salycilat- und Jod-AllergieContraindication
Salycilate and iodine allergy
Nebenwirkungen
Es können lokal Hauttrockenheit oder Schuppen auftreten.Side effects
Dry skin or dandruff may appear locally.
Wechselwirkung mit anderen Mitteln
Eine gleichzeitige Verabreichung von 2×500 mg Proxen verstärkt die
Wirkung und empfehlenswert.Interaction with other means
Simultaneous administration of 2 × 500 mg proxies increases the effect and is recommended.
Dosierung
Dick über oder rund um die schmerzenden Gelenke, Wirbel oder Knochen auftragen.dosage
Apply thickly over or around the painful joints, vertebrae or bones.
Die Salbe soll man am Abend auftragen. Die betreffenden Stellen leicht mit weißem elast. Baumwoll-Gaze überbinden (z. B. den Knie). Bei Handgelenkentzündung soll man weiße Baumwoll-Handschuhe ("Foto"-Handschuh) oder bei Fußgelenkentzündung weiße Baumwoll-Socken aufziehen.The ointment should be applied in the evening. The places concerned easily with white elastic. Tie over cotton gauze (e.g. the knee). At Wrist inflammation is said to be white cotton gloves ("photo" glove) or put on white cotton socks if your ankle is inflamed.
Die Salbe ist am Morgen mit warmen Seifenwasser abzuwaschen.The ointment should be washed off in the morning with warm soapy water.
Bei Wirbel-Arthrosen soll man die betreffenden Stellen nicht abdecken und 3-4 Tagel lang nicht abwaschen.With vertebral arthrosis one should not cover the affected areas and Do not wash off for 3-4 days.
Dauer der Anwendung: bei akuten Entzündungen: ca. 2 Wochen bis alle Entzündungserscheinungen zurückgegangen sind.Duration of use: in acute inflammation: about 2 weeks to all Inflammation symptoms have decreased.
Bei Osteoarthrosen gelegentlich einige Tage lang, bis man völlig schmerzfrei ist.With osteoarthritis, occasionally for a few days until you get completely is painless.
Die Spezialsalbe hat entzündungshemmende, schmerzstillende und baktericide (Jod) Wirkung. Wegen der baktericiden Wirkung ist die Salbe auch bei allen Infektarthritiden mit ausgezeichnetem Erfolg verwendbar.The special ointment has anti-inflammatory, analgesic and bactericidal (Iodine) effect. Because of the bactericidal effect, the ointment is also in everyone Infectious arthritis can be used with excellent success.
Die Abkürzung "PCP" bedeutet: Polyarthritis Chronica Progressiva, auf Deutsch: Progressiv chronische Polyarthritis. Bei dieser Krankheit erkranken erstens fast immer die Kleingelenke, an erster Stelle die Handgelenke. Diese Gelenkentzündung kann zu schweren Deformationen führen, besonders dann, wenn die Krankheit im Frühstadium nicht oder ungenügend behandelt wurde.The abbreviation "PCP" means: Polyarthritis Chronica Progressiva, auf English: Progressive chronic polyarthritis. Ill with this disease firstly, almost always the small joints, in the first place the wrists. This inflammation of the joints can lead to severe deformations, especially when the disease is not treated or treated insufficiently in the early stages has been.
Mit meiner Spezialsalbe ist es möglich, im Frühstadium die Gelenkentzündung zu heilen (PCP gilt bisher als unheilbare Krankheit), ohne Cortison verwenden zu müssen.With my special ointment, it is possible to prevent joint inflammation in the early stages cure (PCP is currently considered an incurable disease) without using cortisone to have to.
Claims (1)
Methylsalicylat: 0,40 Gramm
Jodlösung 5%: 0,80 Gramm
Kaliumjodid: 0,05 Gramm
Eucalyptusöl: 0,2 Gramm
Pfefferminzöl: 0,2 Gramm
Spiritus (verd.): 0,5 Gramm
Bolus alba steril: 142 Gramm
Glycerin ad: 300 GrammDie Spezialsalbe hat entzündungshemmende, schmerzstillende und baktericide (Jod) Wirkung. Wegen der baktericiden Wirkung ist die Salbe auch bei allen Infektarthritiden mit ausgezeichnetem Erfolg verwendbar.
Die Abkürzung "PCP" bedeutet: Polyarthritis Chronica Progressiva, auf Deutsch: Progressiv chronische Polyarthritis. Bei dieser Krankheit erkranken erstens fast immer die Kleingelenke, an erster Stelle die Handgelenke. Diese Gelenkentzündung kann zu schweren Deformationen führen, besonders dann, wenn die Krankheit im Frühstadium nicht oder ungenügend behandelt wurde.
Mit meiner Spezialsalbe ist es möglich, im Frühstadium die Gelenkentzündung zu heilen (PCP gilt bisher als unheilbare Krankheit), ohne Cortison verwenden zu müssen.1. Externally applicable composition for the treatment of chronic joint inflammation on the basis of salicylic acid and its derivatives and essential oils, characterized by the following composition: salicylic acid: 0.25 grams
Methyl salicylate: 0.40 grams
Iodine solution 5%: 0.80 grams
Potassium iodide: 0.05 grams
Eucalyptus oil: 0.2 grams
Peppermint oil: 0.2 grams
Spirit (Verd.): 0.5 grams
Bolus alba sterile: 142 grams
Glycerin ad: 300 grams The special ointment has anti-inflammatory, analgesic and bactericidal (iodine) effects. Because of the bactericidal effect, the ointment can also be used with all infectious arthritis with excellent success.
The abbreviation "PCP" means: Polyarthritis Chronica Progressiva, in German: Progressive chronic polyarthritis. With this disease, first of all, the small joints almost always get sick, first of all the wrists. This inflammation of the joints can lead to severe deformations, especially if the disease has not been treated or has been treated insufficiently in the early stages.
With my special ointment, it is possible to cure the inflammation of the joints in the early stages (PCP has so far been considered an incurable disease) without having to use cortisone.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19934343062 DE4343062C1 (en) | 1993-12-16 | 1993-12-16 | Special liniment for the treatment of all types of joint inflammation, especially rheumatoid arthritis and osteoarthritis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19934343062 DE4343062C1 (en) | 1993-12-16 | 1993-12-16 | Special liniment for the treatment of all types of joint inflammation, especially rheumatoid arthritis and osteoarthritis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE4343062C1 true DE4343062C1 (en) | 1994-08-25 |
Family
ID=6505266
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19934343062 Expired - Lifetime DE4343062C1 (en) | 1993-12-16 | 1993-12-16 | Special liniment for the treatment of all types of joint inflammation, especially rheumatoid arthritis and osteoarthritis |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE4343062C1 (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4445003A1 (en) * | 1994-12-16 | 1996-06-20 | Fhw Feucht Hygiene Werk Gmbh | Agent for disinfecting wounds |
| EP1117299A4 (en) * | 1998-09-30 | 2002-06-05 | West Agro Inc | Stable glycerin iodine concentrate compositions |
| WO2003004000A3 (en) * | 2001-07-06 | 2003-05-08 | Magic Herb Corp | Topical composition for treating pain |
| FR2846240A1 (en) * | 2002-10-24 | 2004-04-30 | Maria Yolanda Aliaga | OINTMENT FOR THE BODY, DESIGNED TO RELIEVE AND MAKE PROGRESSIVE DISAPPEARANCE OF MUSCULAR PAIN, FOULS, SPRAYS, DISORDERS, DECONGESTANTS AND FOR SOOTHING JOINT AND RHUMATISMAL PAIN. |
-
1993
- 1993-12-16 DE DE19934343062 patent/DE4343062C1/en not_active Expired - Lifetime
Non-Patent Citations (2)
| Title |
|---|
| DE-B: Präparate-Liste der Naturheilkunde, J. Sommer u.a. (Hrsg.), Sommer-Verlag, Teningen, 12. Aufl. 1991, S. 297, Nr. 079/0212079 "Rheumafluid FIDES" * |
| DE-B: ROTE LISTE 1991, Bundesverband der Pharmazeut. Industrie e.V., (Hrsg.),Editio Cantor,Aulendorf 1991, Nr. 05501 "Brachialin percutan" * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4445003A1 (en) * | 1994-12-16 | 1996-06-20 | Fhw Feucht Hygiene Werk Gmbh | Agent for disinfecting wounds |
| EP1117299A4 (en) * | 1998-09-30 | 2002-06-05 | West Agro Inc | Stable glycerin iodine concentrate compositions |
| WO2003004000A3 (en) * | 2001-07-06 | 2003-05-08 | Magic Herb Corp | Topical composition for treating pain |
| GB2394662A (en) * | 2001-07-06 | 2004-05-05 | Magic Herb Corp | Topical composition for treating pain |
| FR2846240A1 (en) * | 2002-10-24 | 2004-04-30 | Maria Yolanda Aliaga | OINTMENT FOR THE BODY, DESIGNED TO RELIEVE AND MAKE PROGRESSIVE DISAPPEARANCE OF MUSCULAR PAIN, FOULS, SPRAYS, DISORDERS, DECONGESTANTS AND FOR SOOTHING JOINT AND RHUMATISMAL PAIN. |
| EP1516631A1 (en) * | 2002-10-24 | 2005-03-23 | Maria Yolanda Aliaga | Body ointment having decongestant effect and for the progressive relief of muscular pain, sprains, wrenchs, dislocations, aches and for relief of articular and rheumatic pain |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5976547A (en) | Analgesic and antiphlogistic compositions and therapeutic wrap for topical delivery | |
| ATE162399T1 (en) | TERFANADINE METABOLITES AND THEIR OPTICALLY PURE ISOMERS FOR THE TREATMENT OF ALLERGIC DISEASES | |
| Kenney | Vitiligo treated by psoralens: a long-term follow-up study of the permanency of repigmentation | |
| Reuveni et al. | Diethyltoluamide-containing insect repellent: adverse effects in worldwide use | |
| DE4343062C1 (en) | Special liniment for the treatment of all types of joint inflammation, especially rheumatoid arthritis and osteoarthritis | |
| DK200201483A (en) | Dermatological application and dermatological preparation | |
| FR2714828B1 (en) | Application of riluzole in the treatment of mitochondrial diseases. | |
| August | Cutaneous necrosis due to cetrimide application. | |
| US5314689A (en) | Acyl-carnitine for the treatment and prevention of viral infections | |
| DE3830333C1 (en) | Pharmaceutical composition for the treatment of the eruption caused by herpes viruses | |
| KR920005967A (en) | Ingredients used to treat circulatory diseases and to treat beauty medications | |
| Ali et al. | Clinical evaluation of the efficacy of polyherbal Unani formulations in scabies | |
| US20050013821A1 (en) | Mint extract and related pharmaceutical compositions | |
| Cartwright et al. | This, upon examination, proved | |
| RU2736486C1 (en) | Method of treating scabies | |
| RU2076724C1 (en) | Method of radiation damage treatment | |
| Carpenter et al. | Scabies and pediculosis treated with benzyl benzoate, DDT, benzocaine emulsion | |
| RU93055153A (en) | ANTIBACTERIAL MEANS "ANALGIN" | |
| Easton | Croton Oil in Tic Douloureux | |
| CN1060343C (en) | Anti-infection and anti-inflammation drugs | |
| Johnson | The Kahuna Hawaiian sorcerer: Its dermatologic implications | |
| Manzoor | JARB (SCABIES) AND ITS MANAGEMENT: A COMPREHENSIVE OVERVIEW IN THE LIGHT OF UNANI MEDICINE | |
| Pettit | A simple pharmacopoeia for out-station skin clinics | |
| CN1117840A (en) | Medicinal paper for treating haemorrhoids and protecting anus | |
| von Genersich | The complete washing-out of the intestinal tract as a treatment for cholera and allied conditions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8100 | Publication of the examined application without publication of unexamined application | ||
| D1 | Grant (no unexamined application published) patent law 81 | ||
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee | ||
| 8370 | Indication of lapse of patent is to be deleted | ||
| 8320 | Willingness to grant licences declared (paragraph 23) | ||
| R119 | Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal fee | ||
| R409 | Internal rectification of the legal status completed | ||
| R409 | Internal rectification of the legal status completed | ||
| R081 | Change of applicant/patentee |
Owner name: VERA BANSAGI-BIEBER, DE Free format text: FORMER OWNER: VERA BANSAGI-BIEBER, 81245 MUENCHEN, DE Effective date: 20120719 Owner name: BANSAGI-BIEBER, VERA, DR., DE Free format text: FORMER OWNER: BANSAGI-BIEBER, VERA, DR./MU BUDAPEST, 81245 MUENCHEN, DE Effective date: 20120719 |
|
| R119 | Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal fee | ||
| R409 | Internal rectification of the legal status completed | ||
| R409 | Internal rectification of the legal status completed | ||
| R071 | Expiry of right | ||
| R071 | Expiry of right |